480 related articles for article (PubMed ID: 29404280)
1. Innate Immune Interactions between
Liu JZ; Ali SR; Bier E; Nizet V
Front Cell Infect Microbiol; 2018; 8():2. PubMed ID: 29404280
[No Abstract] [Full Text] [Related]
2. Murine innate immune response to virulent toxigenic and nontoxigenic Bacillus anthracis strains.
Drysdale M; Olson G; Koehler TM; Lipscomb MF; Lyons CR
Infect Immun; 2007 Apr; 75(4):1757-64. PubMed ID: 17242059
[TBL] [Abstract][Full Text] [Related]
3. Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice.
Liu S; Miller-Randolph S; Crown D; Moayeri M; Sastalla I; Okugawa S; Leppla SH
Cell Host Microbe; 2010 Nov; 8(5):455-62. PubMed ID: 21075356
[TBL] [Abstract][Full Text] [Related]
4. Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity.
Crawford MA; Aylott CV; Bourdeau RW; Bokoch GM
J Immunol; 2006 Jun; 176(12):7557-65. PubMed ID: 16751402
[TBL] [Abstract][Full Text] [Related]
5. Resistance of human alveolar macrophages to Bacillus anthracis lethal toxin.
Wu W; Mehta H; Chakrabarty K; Booth JL; Duggan ES; Patel KB; Ballard JD; Coggeshall KM; Metcalf JP
J Immunol; 2009 Nov; 183(9):5799-806. PubMed ID: 19812208
[TBL] [Abstract][Full Text] [Related]
6. Circulating lethal toxin decreases the ability of neutrophils to respond to Bacillus anthracis.
Weiner ZP; Ernst SM; Boyer AE; Gallegos-Candela M; Barr JR; Glomski IJ
Cell Microbiol; 2014 Apr; 16(4):504-18. PubMed ID: 24152301
[TBL] [Abstract][Full Text] [Related]
7. A review of the interaction of Bacillus anthracis with cells of the innate immune response.
Mayer-Scholl A
Berl Munch Tierarztl Wochenschr; 2006; 119(5-6):216-21. PubMed ID: 16729468
[TBL] [Abstract][Full Text] [Related]
8. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
Majumder S; Das S; Somani V; Makam SS; Joseph KJ; Bhatnagar R
Sci Rep; 2018 May; 8(1):7242. PubMed ID: 29740033
[TBL] [Abstract][Full Text] [Related]
9. Anthrax toxins: A paradigm of bacterial immune suppression.
Baldari CT; Tonello F; Paccani SR; Montecucco C
Trends Immunol; 2006 Sep; 27(9):434-40. PubMed ID: 16861036
[TBL] [Abstract][Full Text] [Related]
10. Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity.
Fukao T
Lancet Infect Dis; 2004 Mar; 4(3):166-70. PubMed ID: 14998502
[TBL] [Abstract][Full Text] [Related]
11. Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival.
Ribot WJ; Panchal RG; Brittingham KC; Ruthel G; Kenny TA; Lane D; Curry B; Hoover TA; Friedlander AM; Bavari S
Infect Immun; 2006 Sep; 74(9):5029-34. PubMed ID: 16926394
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
Jang J; Cho M; Lee HR; Cha K; Chun JH; Hong KJ; Park J; Rhie GE
Biochim Biophys Acta; 2013 Mar; 1830(3):2804-12. PubMed ID: 23201204
[TBL] [Abstract][Full Text] [Related]
13. Effects of anthrax toxin components on human neutrophils.
O'Brien J; Friedlander A; Dreier T; Ezzell J; Leppla S
Infect Immun; 1985 Jan; 47(1):306-10. PubMed ID: 3917427
[TBL] [Abstract][Full Text] [Related]
14. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
Welkos S; Little S; Friedlander A; Fritz D; Fellows P
Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
[TBL] [Abstract][Full Text] [Related]
15. Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax.
Lovchik JA; Drysdale M; Koehler TM; Hutt JA; Lyons CR
Infect Immun; 2012 Jul; 80(7):2414-25. PubMed ID: 22526673
[TBL] [Abstract][Full Text] [Related]
16. Edema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages.
Raymond B; Leduc D; Ravaux L; Le Goffic R; Candela T; Raymondjean M; Goossens PL; Touqui L
PLoS Pathog; 2007 Dec; 3(12):e187. PubMed ID: 18069891
[TBL] [Abstract][Full Text] [Related]
17. Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis.
Ebrahimi CM; Sheen TR; Renken CW; Gottlieb RA; Doran KS
Infect Immun; 2011 Jul; 79(7):2510-8. PubMed ID: 21518787
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
Glinert I; Bar-David E; Sittner A; Weiss S; Schlomovitz J; Ben-Shmuel A; Mechaly A; Altboum Z; Kobiler D; Levy H
Antimicrob Agents Chemother; 2016 Aug; 60(8):4878-85. PubMed ID: 27270276
[TBL] [Abstract][Full Text] [Related]
19. Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses.
Xu L; Frucht DM
Int J Biochem Cell Biol; 2007; 39(1):20-4. PubMed ID: 17008119
[TBL] [Abstract][Full Text] [Related]
20. Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model.
Loving CL; Khurana T; Osorio M; Lee GM; Kelly VK; Stibitz S; Merkel TJ
Infect Immun; 2009 Jan; 77(1):255-65. PubMed ID: 18955474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
